CIRM Panel Approves $300,000 Economic Study; Public Access to Data Still a Question
A subcommittee of the directors of the California stem cell agency today unanimously approved a $300,000 economic impact study of the agency's work by a firm that is expected to “execute a vibrant and aggressive strategy” supporting CIRM.
Still up in the air is whether CIRM will allow other researchers and interested parties access to the basic data that…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.